Business
Applied BioSciences Announces Retirement of Convertible Note
Applied BioSciences Announces Retirement of Convertible Note.
About this update from Applied Biosciences Corp.
[{"type":"text","content":"LOS ANGELES, CA / ACCESSWIRE / March 19, 2020 / Applied Biosciences Corp. (OTCQB:APPB), a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics/ biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas, today announced the retirement of $500,000 of convertible investor debt, simplifying the Company's capital structure as it positions for growth."The elimination of variable rate, floating price, convertible notes have strengthened our balance sheet and simplified our capital structure as we position the company for growth," commented Chris Bridges, President and Director of Applied Biosciences. "As we continue to expand product portfolio and expand our clinical pipeline, this is an important step to position the Company for a possible up-listing to a national securities exchange in the near future."About Applied BioSciences Corp.Applied BioSciences is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics/ biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. We also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to our customers. For more information, visit the Company's website.ContactEmail: [email protected] or [email protected] be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.Official Website: www.appliedbiocorp.comSafe Harbor StatementExcept for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to Applied BioSciences Corp. (the "Company") or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections abo...